Michael Greenhalgh
Net Worth

Last updated:

What is Michael Greenhalgh net worth?

The estimated net worth of Mr. Michael Greenhalgh is at least $2,669,281 as of 28 Jun 2023. He has earned $631,631 from insider trading and has received compensation worth at least $2,037,650 in Tabula Rasa HealthCare, Inc..

What is the salary of Michael Greenhalgh?

Mr. Michael Greenhalgh salary is $407,530 per year as Chief Operating Officer in Tabula Rasa HealthCare, Inc..

How old is Michael Greenhalgh?

Mr. Michael Greenhalgh is 63 years old, born in 1962.

What stocks does Michael Greenhalgh currently own?

As insider, Mr. Michael Greenhalgh owns shares in one company:

Company Title Shares Price per share Total value
Tabula Rasa HealthCare, Inc. (TRHC) Chief Operating Officer 162,636 $0 $0

What does Tabula Rasa HealthCare, Inc. do?

Tabula Rasa HealthCare, Inc. operates as a healthcare technology company in the United States. The company operates in two segments, CareVention HealthCare and MedWise HealthCare. It offers EireneRx, a cloud-based medication decision-support and e-prescribing platform to access patient medication-related information; and MedWise medication therapy management software, a cloud-based platform designed to aid in the identification and resolution of medication and health-related problems. The company also provides TruChart that offers electronic health records (EHR), care coordination, and financial management in one program allowing Programs of All-Inclusive Care for the Elderly (PACE) to track measurable outcomes in defined timeframes for the populations they serve; and PACElogic, which delivers sharable workflows comprising EHR, customer relationship management, claims adjudication, electronic data interchange, care management, coordination and planning, integration with community-based providers, and various federal and state that requires reporting. In addition, it offers DoseMeRx, a decision support software that leverages clinically validated pharmacokinetic drug models, patient characteristics, drug concentrations, and genotypes to guide dose optimization; and PrescribeWellness, a PrescribeWellness, a patient engagement center platform. Further, the company provides clinical pharmacist collaboration, prescription fulfillment and adherence packaging, and pharmacy benefit management services, as well as health plan management services, including risk adjustment and third party administrator services. As of December 31, 2021, it served approximately 150 healthcare organizations; and 350 health plans and approximately 18,000 retail pharmacies. The company provides cloud-based software applications to assist prescribers and pharmacists. Tabula Rasa HealthCare, Inc. was founded in 2009 and is headquartered in Moorestown, New Jersey.

TRHC logo
TRHC
Tabula Rasa HealthCare, Inc.

Michael Greenhalgh insider trading

Tabula Rasa HealthCare, Inc.

Mr. Michael Greenhalgh has made 16 insider trades between 2020-2023, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 25,000 units of TRHC stock on 28 Jun 2023. As of 28 Jun 2023 he still owns at least 162,636 units of TRHC stock.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock 25,000 $3.11 $77,750
Option
Employee Stock Option (right to buy) 25,000 $3.11 $77,750
Purchase
Common Stock 2,000 $5.63 $11,260
Sale
Common Stock 2,010 $14.87 $29,889
Sale
Common Stock 1,088 $15.69 $17,071
Sale
Common Stock 1,585 $15.54 $24,631
Sale
Common Stock 1,100 $15.67 $17,237
Sale
Common Stock 2,352 $38.08 $89,564
Sale
Common Stock 3,000 $50 $150,000
Option
Employee Stock Option (right to buy) 3,000 $50 $150,000
Option
Common Stock 3,000 $50 $150,000
Option
Employee Stock Option (right to buy) 4,000 $3.11 $12,440
Option
Common Stock 4,000 $3.11 $12,440
Sale
Common Stock 4,000 $49 $196,000
Sale
Common Stock 1,000 N/A N/A
Option
Employee Stock Option (right to buy) 1,000 N/A N/A
Option
Common Stock 1,000 N/A N/A
Sale
Common Stock 16,000 N/A N/A
Option
Common Stock 16,000 N/A N/A
Option
Employee Stock Option (right to buy) 16,000 N/A N/A
Option
Employee Stock Option (right to buy) 3,000 N/A N/A
Sale
Common Stock 3,000 N/A N/A
Option
Common Stock 3,000 N/A N/A
Sale
Common Stock 966 N/A N/A
Sale
Common Stock 2,568 N/A N/A
Sale
Common Stock 2,568 $41.76 $107,240
Option
Employee Stock Option (right to buy) 1,000 N/A N/A
Option
Common Stock 1,000 N/A N/A
Sale
Common Stock 1,000 N/A N/A
Option
Employee Stock Option (right to buy) 2,000 N/A N/A
Sale
Common Stock 2,000 N/A N/A
Option
Common Stock 2,000 N/A N/A
Option
Employee Stock Option (right to buy) 2,000 N/A N/A
Option
Common Stock 2,000 N/A N/A
Sale
Common Stock 2,000 N/A N/A
Option
Employee Stock Option (right to buy) 3,000 N/A N/A
Option
Common Stock 3,000 N/A N/A

Tabula Rasa HealthCare key executives

Tabula Rasa HealthCare, Inc. executives and other stock owners filed with the SEC:

  • Dr. Calvin H. Knowlton BSc Pharm, MDiv, Ph.D. (75) Co-Founder, Chairman & Chief Executive Officer
  • Dr. Orsula Voltis Knowlton BScPharm, M.B.A., MBA, Pharm.D., PharmD (56) Co-Founder, Pres, Chief Marketing & New Bus. Devel. Officer and Director
  • Mr. Brian W. Adams (43) Co-Pres, Chief Financial Officer & Sec.
  • Mr. Michael Greenhalgh (63) Chief Operating Officer